Reshape Lifesciences Inc.
13F holders, Q1 2025 (March 31)12holders +2
4new positions
2sold out
1famous investor
$0.36avg. 13F price*
At the end of Q1 2025, 12 institutions reported holding Reshape Lifesciences Inc. in their 13F filings, up 2 from Q4 2024. 4 opened new positions and 2 sold out. The largest holders were UBS Group AG ($20K), Renaissance Technologies ($6K) and Geode Capital Management, LLC ($4K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Reshape Lifesciences Inc.
- CUSIP
- 76090R309
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $14K |
| Exits | 2 | $13 |
All 13F filers, Q4 2024 → Q1 2025: 84,607 shares bought and 3 shares sold, net +84,604 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| UBS Group AG | 0.00% | Add +215.1% | 55,667 | $20K |
| Renaissance Technologies | 0.00% | New | 16,300 | $6K |
| Geode Capital Management, LLC | 0.00% | New | 10,872 | $4K |
| Two Sigma Securities, LLC | 0.00% | New | 10,523 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1048.9% | 9,731 | $4K |
| BlackRock, Inc. | 0.00% | No change | 588 | $212 |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 26 | $9 |
| Bank of America Corp. | 0.00% | No change | 6 | $2 |
| Group One Trading LLC | 0.00% | No change | 2 | $1 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 1 | $0 |
| Osaic Holdings, Inc. | 0.00% | No change | 1 | $0 |
| SBI Securities Co., Ltd. | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is RESHAPE LIFESCIENCES INC's weight in each manager's 13F, not the share of Reshape Lifesciences Inc. the manager owns.